Treating Multiple Sclerosis with PEMF
BY JONATHAN BOWEN
The Curatron 3D has significantly improved my quality of life and enabled me to cope with and actually manage my symptoms
Success with PEMF for MS
Spasticity, fatigue, balance, bladder function, energy levels, peripheral neuropathy, and inflammation have all been relieved with Curatron PEMF. Cognitive function and sleep quality are improved with PEMF. Depression and mental anxiety are relieved.
“I was diagnosed with Relapsing-Remitting MS in March of 2007 at the age of 47. My initial symptoms were tingling in hands and feet, fatigue and balance issues which meant injury due to falls. I chose not to take any prescription drugs because I was not convinced they would be of any benefit. In the next 11 years, my left side became weaker, arm and leg, I developed drop foot, have lost fine motor skills in my hand and continue to experience falls. I determined to control my MS through diet and exercise but was always open-minded to alternative non-invasive therapies. In August of 2019, I purchased the Curatron 3D and began using it 3 to 4 times a day. It is easy and convenient to operate. What I initially noticed was that I was sleeping properly at night and waking feeling refreshed, the energy levels I feel are normal for my age, and I have an overall sense of well-being that did not exist prior to using the Curatron. In the last year and a half, I found it takes the edge off or eliminates most pain issues I have; and because I still experience injury due to falls, my recovery is that much quicker when using the machine. I suffer from peripheral neuropathy pain in my left foot and muscle spasms in my left leg, both of which have greatly decreased in regularity. The Curatron 3D has significantly improved my quality of life and enabled me to cope with and actually manage my symptoms.” – Sherri Wiens
Cartilage of a Knee Joint
MS: An Autoimmune Disease
Multiple Sclerosis is an autoimmune disease affecting the central nervous system. The protective sheath that covers the nerve cells in the brain, spinal cord, and optic nerves are damaged, inflamed and hardened.
The nerve cells, called neurons, transfer electrical signals from the brain throughout the body. In MS sufferers, the Myelin sheath, which insulates the nerves, is eroded by mistaken attacks form immune cells and the nerve fibre is damaged, leading to a breakdown in the ability of the nerve cells to transmit signals.
The result in the damage to the Myelin sheath produces a wide range of physical and mental symptoms. If the damage to the Myelin is minimal, nerve signals proceed with minor interruptions; however if the damage is more substantial and scar tissue replaces the Myelin, the nerve signals can be entirely compromised. This is where the term sclerosis comes it. It is derived from the Greek word for hardness. It refers to the scarring tissue that replaces damaged Myelin impeding nerve transmission.
Symptoms of MS
MS can come in waves, with the symptoms disappearing between flare-ups. It can build up over time and cause permanent neurological problems.
According to the Multiple Sclerosis Society of Canada, symptoms of MS include “extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes.”
Other sources list symptoms such as bowel problems, (including incontinence, diarrhea or constipation), muscle spasms, speech issues, difficulties thinking, depression, and high temperatures.
A patient may experience some or all of these symptoms. Because there are so many, diagnosis is often missed at first until proper testing is done.
While the exact cause is not known, the disease is believed to occur because of environmental factors and genetics. Viruses appear to trigger MS.
Women are twice as likely to develop MS over men. The disease usually occurs between the ages of twenty and fifty.
Interestingly, Alonso Hernán documented that MS is more common in people who live farther from the equator in the publication “Temporal trends in the incidence of multiple sclerosis: a systematic review”, (July 2008, Neurology 71 (2): 129–35.). The decrease in the magnetic field of the earth is experienced the most in the Northern Hemisphere.
Anatomy of a Nerve Cell
Medication can prove insufficient to treat MS and has many side effects.
Traditional Pharmacological Treatment
Medication has only a mild effect on MS and can cause many adverse side effects and reactions. Most treatment is geared toward returning the patient to normal function after a flare-up of MS. Some medications include corticosteroids which are taken orally and intravenously. They do not provide a permanent cure, and have side effects such as anxiety, depression, sodium retention, hypertension, muscle wasting, hyperglycaemia, diabetes, colitis, Chron’s disease, peptic ulceration, and others.
PEMF and Physical MS Symptoms
Scientific studies have demonstrated that PEMF can have a significant role in treating MS. PEMF is effective on multiple levels, first it will help repair damage caused to the Myelin sheath, second it will help with neuroplasticity in reprogramming damaged areas of the brain (see Neuroplasticity in the Parkinson’s article).
Many physical symptoms were relieved with PEMF treatment, where patients experienced a “a range of improvements, including improvements in gait, balance, bowel and bladder functions, vision, mood, and sleep.” A “reduction in tremors” was also experienced.
Curatron has the ability to penetrate into the skull and nervous system without invoking involuntary muscle spasms. It provides a relaxing treatment for MS without side effects.
Scientific studies show that PEMF is
“capable of initiating various healing processes including…. multiple sclerosis”
Generally speaking, the reports indicated PEMF has also demonstrated
“improvements in a variety of areas, including fatigue, sleep, vision, bladder function, movement and speech problems, and mood.”
PEMF and Spasticity
One of the visible manifestations of MS is spasticity. Spasticity is the increasing stiffness and a slowdown in movement of the limbs. Over time the patients posture will change due to the muscle weakness. Sometimes involuntary muscle spasms can occur which can be painful. This can cause embarrassment to the patient as they lose control of their motor functions. PEMF has proven to be helpful in this area:
Results of this double-blind, placebo-controlled study indicated that pulsed electromagnetic fields administered daily over a period of 15 days is a generally effective treatment in reducing symptoms associated with multiple sclerosis, with the most positive improvements involving the alleviation of spasticity and pain. (1)
Another study stated:
Results of this double-blind, placebo-controlled study found that pulsed electromagnetic fields administered daily over a period of 15 days proved to be an effective treatment in reducing spasticity and incontinence associated with multiple sclerosis. (2)
PEMF and Fatigue
One of the debilitating symptoms of MS is fatigue. It can ground a patient as they do not have the energy to perform basic daily functions, let alone enjoy outings with their families and friends. Because PEMF can increase oxygenation, nutrient uptake, and ATP production it can maximize the energy levels for someone with MS. Curatron has settings for Oxygenation, Energy Regulation, and Vitalization. Here is what the studies state:
This article reports on the cases of three multiple sclerosis patients experiencing continuous and debilitating daily fatigue over the course of several years. Treatment with extracranially applied flux electromagnetic fields dramatically improved symptoms of fatigue in all three patients. (3)
Another study included fatigue with a whole host of symptoms that were relieved:
This article reports on the case of a 55-year-old female chronic progressive multiple sclerosis patient who received a single external application of magnetic fields which lasted 20 minutes. The treatment quickly led to improvements in a variety of areas, including fatigue, sleep, vision, bladder function, movement and speech problems, and mood. (4)
Walking, Balance and Bladder Function.
MS can also create impairments in balance, muscle weakness, tremors, lack of muscle coordination (ataxia). These drastically affect a person’s mobility and quite often will result in dependence on a walking aid. Again this is caused by the destruction of the insulators surrounding the nerves, the Myelin sheath. Bladder function is impaired due to damage to the sensory nerves which indicate bladder fullness.
PEMF can greatly help with these symptoms as nerve issues are treated with settings on the Curatron device such as neuritis (inflammation of the nerve), neurosclerosis (hardening of the nerve), various types of neuralgia and neuropathy (both forms of nerve pain).
This article reports on the case of a 58-year-old male multiple sclerosis patient with a 37-year history of the disease. Treatment with external application of magnetic fields led to a speedy improvement of neurological symptoms in the areas of walking, balance, sensory symptoms, and bladder function. Improvements in numerous cognitive functions were seen within 24 hours of treatment as well. (5)
The improvements in balance and walking have been significant:
This article reports on the case of a 36-year-old man severely disabled with partial paralysis and lack of coordination. Three treatment sessions per week with pulsed electromagnetic fields over a period of one year led to a range of improvements, including improvements in gait, balance, bowel and bladder functions, vision, mood, and sleep. No progression (worsening) of symptoms associated with multiple sclerosis was seen throughout the course of EMF treatment. (6)
Improved Eyesight with PEMF
MS can affect the eyesight in two different ways.
-
The eyes no longer move together (Internuclear ophthalmoplegia), causing double vision (diplopia). This happens when one eye moves, but the other does not follow. The cause is damage to the myelinated sheaths of the nerves connecting the eyes, and the scaring that occurs.
-
The optic nerves becomes inflamed (optic neuritis), when optic nerve’s myelin sheath (the insulator) is damaged. This causes pain and blurry vision in part or all of the vision field. It can also cause flashes of light. The colour vision in is often less vivid, especially the ability to see red in the affected eye.
PEMF has been proven to be very successful in these areas as it helps with re-myelination (regrowth of myelin) and with reducing scarification and inflammation.
This article reports on the case of a 36-year-old multiple sclerosis patient who experienced immediate improvements in visuoperceptive functions following treatment with external application of magnetic fields. (7)
A later study found the same results:
This study reports on four cases of multiple sclerosis who experienced improvements in visuospatial and visuomotor functions following treatment with external application of low magnetic fields.(8)
Spasticity is a common symptom of Multiple Sclerosis but is treatable by PEMF
PEMF helps with motor function, balance, sensory symptoms, spasticity and fatigue
Cartilage of a Knee Joint
PEMF improves Cognitive Function
One of the areas that MS patients suffer with is cognitive impairment. The inability to put thoughts together, sometimes referred to as brain fog. PEMF demonstrated significant results in this area:
This article reports on the cases of three patients suffering from long-time symptoms of multiple sclerosis who received treatment with extra cerebral pulsed electromagnetic fields over a period of between 6 and 18 months. Results showed all three patients experienced significant improvements in cognitive functions. (9)
Improving Reading with PEMF
The other cognitive area that is recognized is the ability to understand written words know as alexia.
This article reports on the cases of three multiple sclerosis patients suffering from alexia (lack of understanding of written words) who experienced a reversal of the alexia following the start of electromagnetic field treatment. (10)
Studies indicated, “patients experienced significant improvements in cognitive functions.” These cognitive functions included problems understanding words (Alexia), as patients experienced a “reversal of the alexia following the start of electromagnetic field treatment.”
Improving Speech with PEMF
MS sufferers will have issues such as slurred speech, or a slow down in talking speed, problems with pronunciation (or articulation called dysarthria). Again this is caused by scarification of the myelin sheath (the insulators) on the nerves that affect speaking.
…a 55-year-old female chronic progressive multiple sclerosis patient who received a single external application of magnetic fields which lasted 20 minutes. The treatment quickly led to improvements in… speech problems. (11)
The dramatic results of PEMF have been proven over and over:
This is a report on the cases of two chronic multiple sclerosis patients exhibiting severe speech problems. Symptoms were completely resolved following 3-4 weeks of treatment with pulsed electromagnetic fields. (12)
Again word fluency was dramatically increased:
This article reports on the cases of three female multiple sclerosis patients with poor word fluency who experienced a 100-percent increase in word output following 4-5 sessions of treatment with electromagnetic fields. (13)
PEMF and Mental Health for MS Sufferers
Depression & Suicidal Tendencies
The emotional cost on MS sufferers can be significant. Struggling to cope with the ever-expanding array of symptoms can be significant. Clinical depression is fairly typical. This can be exacerbated by side effects from medications used to treat MS. Feelings of anger, anxiety, frustration and hopelessness are found to greater and lesser extents at different stages of the disease. Suicide is also a possible issue. PEMF devices that have the ability to penetrate the brain can treat clinical depression. The Curatron 3D system has this ability. The fact that many symptoms can also be alleviated will help with a positive outlook and remove the feeling of hopelessness.
The cases of three female multiple sclerosis patients exhibiting suicidal behavior are discussed in this article. Treatment with pulsed electromagnetic fields resolved the suicidal behavior in all three patients, an improvement that was maintained over a follow-up period of 3.5 years. (14)
(see this article on depression)
Sleep
Impairment in sleep can also be a significant factor in both fatigue and depression. This can be caused by chronic pain, medications, involuntary movement, and increase in muscle tension (hypertonicity). PEMF can help with alleviating the symptoms causing sleep depravation, but Curatron also has settings for relaxation, relaxation EEG, sleep disturbances, sedation and anti-stress. Several of the citations in this article list improvements in sleep as a positive benefit of PEMF.
(See this article on sleep)
Clinical depression is typical with Multiple Sclerosis
Curatron PEMF for MS
Curatron has several models that will help Multiple Sclerosis sufferers cope with their conditions, and improve their quality of life. The Curatron PC and the Curatron 3D both have computer programs that allow a wide array of specific treatments for the symptoms outlined above.
The curatron PC system treats an array of symptoms for MS sufferers. The Curatron 3D System adds to this the ability to penetrate the brain with settings for depression.
References:
-
A. Guseo, Pulsing Electromagnetic Field Therapy of Multiple Sclerosis the Gyuling- Bordacs Device: Double-Blind, Cross-Over and Open Studies, Journal of Bioelectr., 6(1), 1987, p. 23-35.
-
A. Guseo, Double-Blind Treatments with Pulsating Electromagnetic Field in Multiple Sclerosis, Hungarian Symposium on Magnetotherapy, 2nd Symposium, May 16-17, 1987, Szekesfehervar, Hungary, p. 85-89.
-
R. Sandyk, Treatment with Weak Electromagnetic Fields Improves Fatigue Associated with Multiple Sclerosis, International Journal of Neurosci, 84(1-4), February 1996, p. 177-186.
-
R. Sandyk, “Rapid Normalization of Visual Evoked Potentials picoTesla Range Magnetic Fields in Chronic Progressive Multiple Sclerosis,” International Journal of Neurosci, 77(3-4), August 1994, p. 243-259.
-
R. Sandyk & R.P. Iacono, “Improvement PicoTesla Range Magnetic Fields of Perceptual-motor Performance and Visual Memory in a Patient with Chronic Progressive Multiple Sclerosis,” International Journal of Neurosci, 78(1-2), September 1994, p. 53-66.
-
R. Sandyk, “Treatment with Electromagnetic Field Alters the Clinical Course of Chronic Progressive Multiple Sclerosis–A Case Report,” International Journal of Neurosci, 88(1-2), November 1996, p. 75-82.
R. Sandyk & R.P. Iacono, “Multiple Sclerosis: Improvement of Visuoperceptive Functions PicoTesla Range Magnetic Fields,” International Journal of Neurosci, 74(1-4), January-February 1994, p. 177-189. -
R. Sandyk, “Further Observations on the Effects of External picoTesla Range MagneticFields on Visual Memory and Visuospatial Functions in Multiple Sclerosis,” International Journal of Neurosc, 77(3-4), August 1994, 203-27
-
R. Sandyk, “Progressive Cognitive Improvement in Multiple Sclerosis from Treatment with Electromagnetic Fields,” International Journal of Neurosci, 89(1-2), January 1997, p. 39-51.
-
R. Sandyk, “Reversal of Alexia in Multiple Sclerosis Weak Electromagnetic Fields,” International Journal of Neurosci, 83(1-2), November 1995, p. 69-79.
-
R. Sandyk, “Rapid Normalization of Visual Evoked Potentials picoTesla Range Magnetic Fields in Chronic Progressive Multiple Sclerosis,” International Journal of Neurosci, 77(3-4), August 1994, p. 243-259.
-
R. Sandyk, “Resolution of Dysarthria in Multiple Sclerosis Treatment with Weak Electromagnetic Fields,” International Journal of Neurosci, 83(1-2), November 1995, p. 81-92.
-
R. Sandyk, Improvement in Word-fluency Performance in Patients with Multiple Sclerosis Electromagnetic Fields,” International Journal Neurosci, 79(1-2), November 1994, p.75-90.
-
R. Sandyk, “Suicidal Behavior is Attenuated in Patients with Multiple Sclerosis Treatment with Electromagnetic Fields,” International Journal of Neurosci, 87(1-2), October 1996, p. 5-15.